ZA977794B - Treatment of pain. - Google Patents

Treatment of pain.

Info

Publication number
ZA977794B
ZA977794B ZA9707794A ZA977794A ZA977794B ZA 977794 B ZA977794 B ZA 977794B ZA 9707794 A ZA9707794 A ZA 9707794A ZA 977794 A ZA977794 A ZA 977794A ZA 977794 B ZA977794 B ZA 977794B
Authority
ZA
South Africa
Prior art keywords
pain
treatment
dopa
antidepressant
neurotransmitters
Prior art date
Application number
ZA9707794A
Other languages
English (en)
Inventor
David Frederick Horrobin
Cari Loder
Graham Cooper
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of ZA977794B publication Critical patent/ZA977794B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9707794A 1996-08-29 1997-08-29 Treatment of pain. ZA977794B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9617990.8A GB9617990D0 (en) 1996-08-29 1996-08-29 Treatment of pain

Publications (1)

Publication Number Publication Date
ZA977794B true ZA977794B (en) 1998-04-17

Family

ID=10799070

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9707794A ZA977794B (en) 1996-08-29 1997-08-29 Treatment of pain.

Country Status (11)

Country Link
US (2) US6451788B1 (de)
EP (1) EP1007053B1 (de)
AT (1) ATE331521T1 (de)
AU (1) AU733088B2 (de)
DE (1) DE69736249T2 (de)
DK (1) DK1007053T3 (de)
ES (1) ES2264806T3 (de)
GB (1) GB9617990D0 (de)
PT (1) PT1007053E (de)
WO (1) WO1998008520A1 (de)
ZA (1) ZA977794B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9617990D0 (en) * 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain
AU3485999A (en) * 1998-04-10 1999-11-01 Mayo Foundation For Medical Education And Research Neo-tryptophan
ES2292238T3 (es) * 1998-04-24 2008-03-01 Scarista Limited Tratamiento de la depresion y preparaciones farmaceuticas para el mismo.
GB9904252D0 (en) * 1999-02-24 1999-04-21 Worsley Andrew P Composition for the treatment of pain
US6575147B2 (en) * 1999-02-25 2003-06-10 Go-Tec Internal combustion system adapted for use of a dual fuel composition including acetylene
GB9906808D0 (en) * 1999-03-24 1999-05-19 Kilgowan Limited Formulation for treatment of pain
US6403657B1 (en) * 1999-10-04 2002-06-11 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity
US6759437B2 (en) * 1999-10-04 2004-07-06 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity including cysteine
GB2355191A (en) * 1999-10-12 2001-04-18 Laxdale Ltd Combination formulations for fatigue, head injury and strokes
GB0216027D0 (en) 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
CA2475763A1 (en) * 2002-02-12 2003-08-21 Cypress Bioscience, Inc. Methods of treating attention deficit/hyperactivity disorder (adhd)
US20070293571A1 (en) * 2006-06-08 2007-12-20 Hinz Martin C Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
EP1490073A4 (de) * 2002-03-21 2006-02-01 Martin C Hinz Segmentoptimierungstechnik für das serotonin- und catecholamin-system
US20090311795A1 (en) * 2002-03-21 2009-12-17 Hinz Martin C Bilateral control of functions traditionally regulated by only serotonin or only dopamine
CN1662231A (zh) * 2002-04-24 2005-08-31 柏树生物科学公司 包括应激相关障碍在内的功能性躯体障碍的预防与治疗
CA2484482C (en) * 2002-05-30 2011-07-26 Neurosearch A/S Triple monoamine reuptake inhibitors for the treatment of chronic pain
US8134029B2 (en) * 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
EP1558231A4 (de) * 2002-10-03 2010-09-08 Cypress Bioscience Inc Dosiseskalation und geteilte tagesdosis von antidepressiva zurbehandlung von neurologischen erkrankungen
MXPA05008943A (es) * 2003-02-21 2005-11-08 C Hinz Martin Tecnologia de optimizacion del segmento de sistema de serotonina y catecolamina.
WO2004105690A2 (en) * 2003-05-23 2004-12-09 Cypress Bioscience, Inc. Treatment of chronic pain associated with drug or radiation therapy
JP4638685B2 (ja) * 2003-06-10 2011-02-23 ハイデルベルガー ドルツクマシーネン アクチエンゲゼルシヤフト オフセット印刷機による印刷の際に湿し水を調量する方法
GB0313630D0 (en) * 2003-06-12 2003-07-16 Wwk Trust The Compositions for the enhanced treatment of depression
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
WO2005048926A2 (en) 2003-11-13 2005-06-02 The General Hospital Corporation Methods for treating pain
PL1708690T3 (pl) 2003-11-17 2017-01-31 Biomarin Pharmaceutical Inc. Leczenie fenyloketonurii za pomocą BH4
KR20070084270A (ko) 2004-11-17 2007-08-24 바이오마린 파머수티컬 인크. 안정한 정제 제형물
JP2008523090A (ja) * 2004-12-08 2008-07-03 バイオマリン ファーマシューティカル インコーポレイテッド 新生児肺高血圧症の治療のための方法および組成物
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
US7750101B2 (en) * 2005-09-28 2010-07-06 Daicel Chemical Industries, Ltd. Polycyclic ester containing cyano group and lactone skeleton
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
WO2007067570A1 (en) * 2005-12-05 2007-06-14 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease
US20090306050A1 (en) * 2006-02-03 2009-12-10 Timothy Dinan Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain
WO2007100718A2 (en) * 2006-02-24 2007-09-07 Denise Barbut Neurotensin receptor agonists and opioid receptor agonists
DK2816024T3 (en) 2006-03-31 2017-10-30 Sunovion Pharmaceuticals Inc CHIRALE AMINER
AU2007254751A1 (en) * 2006-05-31 2007-12-13 Sepracor Inc. Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide
US20100009997A1 (en) * 2007-01-12 2010-01-14 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiarty disorder with a bh4 derivative prodrug
US20080220104A1 (en) * 2007-03-08 2008-09-11 Cappello John V Compositions for producing satiety
LT2545939T (lt) 2007-04-11 2021-03-10 Biomarin Pharmaceutical Inc. Tetrahidrobiopterinas, skirtas gydyti ligas, susijusias supadidėjusiu fenilalanino kiekiu
EP2629615B1 (de) 2010-10-22 2018-10-10 Duke University Retardformulierungen aus 5-hydroxytryptophan als zusatz für pro-serotonergische therapien
JP2014503592A (ja) * 2011-01-26 2014-02-13 ニコ ワールドワイド，インコーポレイテッド 片頭痛の療法
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
ITUB20153879A1 (it) * 2015-09-24 2017-03-24 Professional Dietetics Spa Composizioni per il trattamento del dolore in pazienti sottoposti ad artroplastica elettiva

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431670A (en) * 1980-12-19 1984-02-14 Bernardo Heller D-Phenylalanine treatment
US4652559A (en) * 1982-08-16 1987-03-24 The Upjohn Company 2-(Phenylmethylene)cycloalkyl-azetidines
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
CA2200761C (en) * 1994-10-05 2008-02-26 Cari Loder Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound
EP0942751B1 (de) 1996-07-05 2002-09-25 The WWK Trust Zusammensetzungen zur behandlung der peripheren neuropathie, die antidepressiven verbindungen und/oder monoamino-oxidaseinhibitoren und/oder vitamin b12 und/oder neurotransmitter-vorläufer oder induktoren enthalten
GB9617990D0 (en) * 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain

Also Published As

Publication number Publication date
EP1007053A1 (de) 2000-06-14
AU4025397A (en) 1998-03-19
DE69736249D1 (de) 2006-08-10
EP1007053B1 (de) 2006-06-28
ES2264806T3 (es) 2007-01-16
GB9617990D0 (en) 1996-10-09
AU733088B2 (en) 2001-05-03
US20020187958A1 (en) 2002-12-12
US6989380B2 (en) 2006-01-24
DE69736249T2 (de) 2007-05-24
DK1007053T3 (da) 2006-10-30
US6451788B1 (en) 2002-09-17
WO1998008520A1 (en) 1998-03-05
PT1007053E (pt) 2006-11-30
ATE331521T1 (de) 2006-07-15

Similar Documents

Publication Publication Date Title
ZA977794B (en) Treatment of pain.
ATE241351T1 (de) Isobutylgaba und dessen derivate zur schmerzbehandlung
AU1718400A (en) Method for treating pain
CA2304657A1 (en) Treatment of conduct disorder
ZA989014B (en) Process for the microbial production of amino acids of the aspartate and/or glutamate family and means used in the process.
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
DE69616375D1 (de) Nicht-allosterische GABA A Agonisten zur Behandlung von Schlafstörungen
GR3036548T3 (en) Apparatus and method for preparing solid forms with controlled release of the active ingredient
ATE213005T1 (de) Kontinuierliches polymerisationverfahren von polyamiden
RU94022017A (ru) Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
DE69715000D1 (de) Verabreichung von gm-csf zur behandlung der gehirntumoren und verhütung deren wiederauftretens
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ZA972345B (en) Use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders.
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
GB9612710D0 (en) Method of treatment
PL318292A1 (en) Application of selegyline in treating epileptic seizures
IL130642A0 (en) N-(pyridinylamino)isoindolines and related compounds
DE69909395D1 (de) Zusammensetzung mit ketanserin und carnitin zur behandlung von crps
BR0112460A (pt) Método para tratamento de sépsis
BG102053A (en) Pyrrolidinyl methyl indole salt
PL331350A1 (en) Verapamil as a drug fro treating stenocardia
RU96100632A (ru) Способ лечения импотенции
MX9710075A (es) Antagonistas melatonina para el tratamiento en la hiperplasia prostatica benigna.